Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $128,916 | $153 | $151 | $1,892 |
| - Cash | $40 | $11 | $69 | $157 |
| + Debt | $2 | $3 | $5 | $5 |
| Enterprise Value | $128,879 | $145 | $87 | $1,740 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | $9 | $10 | -$67 | -$125 |
| % Margin | – | – | – | – |
| Net Income | $7 | $43 | -$68 | -$126 |
| % Margin | – | – | – | – |
| EPS Diluted | 6.805 | 39,311.069 | -48,889.111 | -102,517.747 |
| % Growth | -100% | 180.4% | 52.3% | – |
| Operating Cash Flow | $9 | $2 | -$76 | -$113 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | $9 | $2 | -$76 | -$114 |